Johnson Varghese

Johnson Varghese has extensive work experience in the pharmaceutical and biotechnology industry. Johnson is currently serving as the VP of Analytical Sciences and Development at Beam Therapeutics since March 2022. Prior to this, they held the position of Head of Method Lifecycle, Global Quality AS&T (Bio and Pharma) at Bristol Myers Squibb from December 2019 to April 2022. Johnson also worked at Celgene as the Executive Director and Head of Analytical Development and Clinical QC for Biologics from October 2016 to December 2019.

Before joining Celgene, they held senior positions at Shire, where they served as the Senior Director and Head of Analytical Development from July 2012 to September 2016. Prior to that, they worked as the Director and Head of Analytical Development from July 2012 to March 2014. Johnson also gained experience at MedImmune as an Associate Director from August 2008 to June 2012.

Johnson'searlier career includes roles at Amgen, where they held positions of Director, Principal Scientist, and Senior Scientist from 1999 to 2008. Johnson started their professional journey as a Scientist at Abbott, PPD, where they worked from April 1994 to November 1999.

Johnson Varghese attended King's College London from 1989 to 1992. No information about the degree or field of study was provided.